SOURCE: BioTech Medics, Inc.

BioTech Medics, Inc.

March 29, 2011 13:00 ET

BioTech Medics Commences Major SHBAN Alcohol Free Hand Sanitizer Marketing Campaign

DALLAS, TX--(Marketwire - March 29, 2011) - BioTech Medics, Inc., (PINKSHEETS: BMCS) announced today the commencement of a major 26 week U.S. advertising campaign featuring SHBAN™ Alcohol Free Hand Sanitizer. The purpose of the campaign is to bring the SHBAN name to the retail public and increase SHBAN sales nationwide.

Today SHBAN will be featured on FamilyNet HD and originating from San Diego on "Mom's Town" at 1PM-EDST on the ComStar Media Cable Network of approximately 34 million households.

Mom's Town provides busy moms with engaging and entertaining informational programming. Heather & Mary, the show hosts are two best-selling authors who have been featured on The CBS Early Show, Dr. Phil, Montel and countless talk shows.

Keith Houser, CEO of BioTech and Tom Wood, Sr. VP of Sales will be discussing the superiority of SHBAN over alcohol gels during the program. Mr. Wood will be demonstrating the long-lasting ability of SHBAN. The question is asked: Would any Mom or person only put on deodorant for just 30 seconds? The obvious answer is No! So why do people use alcohol gels that last only 30 seconds? Mr. Houser demonstrates how a person using alcohol gels on their hands near a flame source can catch fire from the alcohol fumes due to the fact alcohol gels are a Class I fire hazard.

SHBAN is owned by BioTech Medics and has 4 granted US Patents protecting its proprietary properties. SHBAN has been clinically tested for over 17 years. SHBAN's active ingredient is FDA approved. SHBAN is colorless, odorless, lasts up to 4 hours when used as directed and is a green product made in the USA.

BioTech will be making additional announcements over the next months as to the various media outlets that will be featuring SHBAN.

Legal Notice: The FDA has made no evaluation of the SHBAN statements in this press release. SHBAN is not for the diagnosis, cure and/or the treatment of any disease.

Safe Harbor for Forward-Looking Statements.
This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. This is not an offer to buy or sell any security. Void where prohibited.

Contact Information

  • Contact:
    Tom Wood
    VP Sales